Preventive oncology (cancer prevention) focuses on key measures that reduce the risk of developing cancer or recurrence of cancer. According to the World Health Organization 30–50% of all cancers are preventable through changes to lifestyle and environmental factors. Prevention offers the most effective long-term strategy for the control of cancer.

Cancer prevention is achieved through primary, secondary and tertiary methods:

  1. Primary Cancer Prevention : Primary prevention is achieved through the promotion of health & wellness (healthy diet, exercise) and reduction of risks (avoiding tobacco & alcohol usage and vaccination).
    1. Human papillomavirus (HPV) vaccination – helps prevent oropharyngeal, cervical, vaginal, vulvar, penile and anal cancers (for individuals aged 9-26 years). Get Human papillomavirus (HPV) vaccination in Vijayawada -
    2. Hepatitis B Virus (HBV) vaccination – helps prevent liver cancer. Get Hepatitis B Virus (HBV) vaccination in Vijayawada
  2. Secondary Cancer Prevention : Secondary prevention includes screening and early detection of cancer before the onset of symptoms.
  3. Tertiary Cancer Prevention : Tertiary prevention focuses on delaying the progression and preventing the complications (secondary malignancies) in those individuals who have already been diagnosed with a malignancy/cancer.

Next Generation Sequencing (NGS) based Cancer screening and diagnostic tests in Vijayawada

Genetic Screening services for Preventive Oncology

Cancer screening is used to detect the cancer at early stage (secondary prevention) and to prevent the additional complications (territory prevention) in those cases already diagnosed with cancer.

  1. Cancer screening services in vijayawada, Andhra Pradesh – helps in early detection of cancer before the onset of symptoms.
  2. Germline cancer / hereditary cancer testing in vijayawada, Andhra Pradesh – helps to identify the risk of common hereditary cancers.
  3. Homologous recombination repair (HRR) testing in vijayawada, Andhra Pradesh – helps to identify prognostic & predictive biomarker for platinum-based chemotherapy and PARP inhibitor therapy.
  4. Homologous recombination deficient (HRD) testing in vijayawada, Andhra Pradesh – provides crucial diagnostic information to guide treatment and predicts likely benefit from PARP inhibitors.
  5. Tumor Mutational Burden (TMB) testing in vijayawada, Andhra Pradesh – helps in predicting clinical responses to immunotherapy (immune check point inhibitors). It also provides chemo-sensitivity & chemo-resistance information and may help guide treatment decisions for metastatic cancers.
  6. Liquid biopsy testing in vijayawada, Andhra Pradesh – non-invasive predictive biomarker testing for screening of early-stage cancers and monitoring treatment response.